In patients with chronic myeloid leukemia (CML), research has revealed grancalcin as a catalyst for K63-linked ULK1 ubiquitination via TRAF6 activation. Here, TRAF6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.